Abstract:Abstract Introduction We investigated whether baseline sleep measures derived from actigraphy the night before total sleep deprivation (TSD) predicted cognitive performance and subjective sleepiness and fatigue during TSD. We also investigated whether these measures during TSD predicted that night’s recovery sleep. Methods Thirty-two adults (ages 27-53;14 females) participated in a five-day experiment under controlled conditions comprised of two baseline 8h time in bed (TIB) nights (B1, B2), approximately 39h of TSD, and two recovery nights of 8-10h TIB (R1=10h, R2=8h). Neurobehavioral measures including the Digit Symbol Substitution Test (DSST), Digit Span (DS), the 10-minute Psychomotor Vigilance Test (PVT), the Karolinska Sleepiness Scale, and the Profile of Mood States Fatigue scale were collected at 0400h, 1130h, and 1730h during TSD. During the second baseline night (B2) and the first recovery night (R1), wrist actigraphy (Actiwatch Spectrum) assessed sleep indices including sleep duration, sleep onset latency (SOL), wake after sleep onset (WASO), sleep efficiency (SE), percent sleep, and the timing of sleep onset, offset, and midpoint. Pearson’s correlations determined relationships between B2 sleep and TSD neurobehavioral measures and between TSD neurobehavioral and R1 sleep measures (p< 0.05 was significant). Results Greater SE at baseline was significantly associated with less subjective sleepiness during TSD (r=−0.415;r2=0.172), and a later sleep onset (r=−0.409;r2=0.167) and a later midpoint (r=−0.376; r2=0.142) were significantly correlated with less subjective fatigue during TSD. Higher DSST scores during TSD were significantly associated with shorter duration, greater SOL, and a later sleep onset during recovery (r:−0.473-0.547; r2:0.172-0.299). Similarly, higher DS scores significantly correlated with later sleep onset (r=0.370; r2=0.137). Fewer PVT lapses during TSD were significantly associated with shorter duration, higher SE, lower WASO, higher percent sleep, and an earlier sleep offset during recovery (r:−0.417-0.489; r2:0.136-0.239). Conclusion Our novel findings demonstrated that measures of sleep continuity and timing the night before TSD predicted resilience to subjective sleepiness and fatigue, but not cognitive performance during TSD. By contrast, cognitive but not subjective performance resilience during TSD predicted that night’s recovery sleep duration, continuity, and timing. Thus, actigraphic measures uniquely predict subjective responses to TSD and reflect cognitive performance responses during sleep loss. Support (if any) NASA grants NNX14AN49G and 80NSSC20K0243 (NG)

0030 Gene Expression and Attention Lapses with a Countermeasure for Sleep Loss

Exploring gene expression biomarker candidates for neurobehavioral impairment from total sleep deprivation

0178 Cumulative Effects of Mild Sleep Restriction on Lapses of Attention

Behavioral and genetic markers of sleepiness

A Genetic Polymorphism of the Human Dopamine Transporter Determines the Impact of Sleep Deprivation on Brain Responses to Rewards and Punishments

Using a Single Daytime Performance Test to Identify Most Individuals at High-Risk for Performance Impairment during Extended Wake

The role of the fronto-parietal network in modulating sustained attention under sleep deprivation: an functional magnetic resonance imaging study

Predictors of interindividual differences in vulnerability to neurobehavioral consequences of chronic partial sleep restriction

Genomic analysis of sleep deprivation reveals translational regulation in the hippocampus

Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men

“Omics” Approaches for Sleep and Circadian Rhythm Research: Biomarkers for Identifying Differential Vulnerability to Sleep Loss

Prediction of Vigilant Attention and Cognitive Performance Using Self-Reported Alertness, Circadian Phase, Hours since Awakening, and Accumulated Sleep Loss

Cognitive Enhancing Effects of Modafinil in Healthy Volunteers

0205 Catechol-O-methyltransferase Genotype, but not Dopamine Receptor D2 Genotype, Modulates Slow Wave Sleep

Fighting Sleep at Night: Brain Correlates and Vulnerability to Sleep Loss

Blood-Gene Expression Reveals Reduced Circadian Rhythmicity in Individuals Resistant to Sleep Deprivation

Molecular and anatomical signatures of sleep deprivation in the mouse brain

Insights into Behavioral Vulnerability to Differential Sleep Pressure and Circadian Phase from a Functional ADA Polymorphism

0172 Predictive Relationships Between Baseline and Recovery Sleep and Neurobehavioral Measures During Sleep Deprivation

Catechol-O-methyltransferase, dopamine, and sleep-wake regulation

0274 Associations of TNFα Gene Polymorphism with Resilience to Sleep Deprivation and Caffeine Sensitivity